Carotid artery stenosis accounts for 20 percent of all ischemic strokes in Western countries. 11) Carotid artery stsenting (CAS) is emerging as an alternative to classic carotid endarterectomy (CEA) to treat carotid artery stenosis. 1)11) Additionally, improvements in endovascular technique and the development of protective devices have dramatically reduced CAS
INTRODUCTION
tracranial hemorrhage (ICH), cerebral hyperperfusion syndrome (CHS), stroke, and restenosis after CEA have been well documented, but few reports of neurological outcomes have been made in patients with CAS especially in Asian population. Therefore, the purpose of this study is to study the neurological results of patients receiving CAS from a single institution. 1)23)
MATERIALS AND METHODS

Patient selection
From January 2013 to June 2018, 97 patients who received CAS for carotid stenosis registered for the study from a single institution. Neurologists and vascular surgeons selected patients suitable for CAS. We performed digital subtraction angiography (DSA) to estimate the degree of stenosis. According to ECST criteria, the indications for CAS were more than 70%
(n = 65 (63.16%) with symptom (transient ischemic attack (TIA) or stroke at the site supplied by the stenotic artery) or in asymptomatic cases, more than 70%
(n = 32 (36.84%)) on DSA. Our institution's routine douplex ultrasound tests conducted follow-up management regularly six months after stent insertion.
After CAS, neurological complications such as ipsilateral or contralateral stroke, resenosis, and hyperperfusion were recorded, analyzed. And the characteristics and conditions before and after procedure was also recorded and reviewed as well.
In Nov. 1999, our CAS program was started at the single neurovascular center. For internal quality con- showed independent risk factors associated with post procedural neurological complications, statistically.
Interestingly, DM showed association with the risk of CAS complications in negative OR (Table 3) .
DISCUSSION
According to American Guidelines for the Prevention (range, 0.36% to 4.5%), respectively and CHS may be fatal once an intracranial hemorrhage occurs. 17) In this study, 13 cases (13.4%) were shown in all cases conforming to the above definition of HPS, but HPS with fetal ICH reported was 1 case (1.1%) in our institution.
This increase in morbidity is associated with increased blood flow through the cerebral artery after the procedure and inadequate arterial blood pressure control. 2) Although we found this phenomenon to be present after CEA for the first time, many authors have reported that post carotid angioplasty and stenting have similar results. 7)21)
The most common time period for occurrence of CHS is several hours to several days after the procedure. 20 The pathogenesis and risk factors of CHS are not fully known, but uncontrolled hypertension seems to be the most important cause of CHS. 5) It stimulates the occipital-parietal region more noticeably because of the sympathetic nerves that innervate very little on the vertebrobasilar circulation. 22) This suggests that impaired cerebral autoregulation, baroreceptor-reflex breakdown, and an axon-like trigeminovascular reflex contribute to the pathogenesis of CHS. 16)17) Another serious concern is the intake of antiplatelet and statins, which is recommended for patients with carotid stenosis before and after procedure. 5) These drugs can increase the risk of cerebral hemorrhage and CHS, especially after carotid stenting. 20) ICH is the most disasteric event secondary to hyperperfusion, which is also associated with CAS. 17) ICH can cause vomiting or change of mentality because of increased pressure in the cranium. 1) It is important to note that ICH after CAS is difficult to prevent because it appears to occur within few hours without symptoms and mostly unavoidable and even fatal. 17) There are several risk factors, including preoperative hypertension, bilateral carotid disease or contralateral carotid occlusion as well as impaired cerebrovascular reserve, which were associated with the formation of ICH after the procedure. 7) It is known that ICH, which appears immediately after CAS, is caused by the rupture of the perforating artery in the basal ganglia hence the sudden exposure of normal perfusion pressure pathophysiologically. 17) Rate of morbidity and mortality are high in both patients who treated with open surgery or endovascular repair, therefore it is crucial to prevent such a catastrophic event after the procedure. 3)7)
Stroke complications
Stroke occurs more commonly after CAS than after CEA. The periprocedural strokes in CREST were most commonly minor, ipsilateral to the treated artery, and ischemic in type and occurred twice as frequently in the CAS arm. 9) Major stroke occurred in 0.6% There is evidence of a higher risk of stroke and mortality after CAS in patients with symptomatic patients than in asymptomatic patients, but it has not yet been studied how certain symptoms affect previously symptomatic patients after CAS procedure. 12) 
Risk factors of CAS
In this study, we analyzed all patients who underwent CAS to identify potential clinical risk factors for neurologic complications after CAS procedure. The significance of this study is that no previous studies analyzing the effects of CAS on post-procedural results have been reported, particularly in Asia, and based on evidence that the risk of stroke and death after CEA depends not only on symptoms but also on the type of presenting event. 11)12) In some studies, age was identified as an independent risk factor for neurologic complications after CAS procedure, but DM and preoperative NIHSS were found to be related to our study. Hyperlipidemia has also been described as a risk factor in patients with complication after CAS that the presence of diabetes was associated with an increased periprocedural risk, but did not show any additional risk as a result of long-term follow-up and had a higher rate of restenosis in diabetic patients. 18) Therefore, these studies are not comparable to our results. Studies suggesting that post-surgical risk for DM patients may be higher after CEA. 6) And this may be helpful in selecting the appropriate technique for carotid revascularization in patients best suited to the procedure type. In some studies, clinical symptoms have also been known to be potential risk factors for periprocedural complications following CAS, but not in accord with our study. However, this association is reported to be consistently insignificant in other studies as well, therefore we could come to a conclusion that it is not significant. 10) The cause of this conflicting result may be a small number of patients.
Study limitation
Several limitations should be pointed out. There may be some neurological complications that the even patient has not noticed would have been missed. The size of the data was small. Without a randomized control group, no clear comparison of CEA or other medical treatment can be made. Since the current data is collected as a single center experience, the results cannot be generalized in a simple way.
CONCLUSION
CAS is a relatively safe and reliable procedure that provides long-term outcome for patients with carotid artery stenosis. However, it is necessary to recognize the incidence of complications after CAS procedure in carotid artery stenosis patients, and careful observation of possible complications after procedure is necessary for patients with a history of pretreatment radiotherapy or high NIHSS score.
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